Chatbot for Mental Health Issues

N/A

Waitlist Available

Led By Nicholas C Jacobson, PhD

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if a chatbot using artificial intelligence can effectively provide support for people with anxiety, depression, or eating issues.

Who is the study for?

This trial is for people who experience anxiety, depression, or eating disorders as confirmed by specific questionnaires (PHQ-9 for depression, GADQ-IV for anxiety, and SWED 3.0 for eating concerns). Participants will be recruited online through various platforms like Facebook and Reddit.

What is being tested?

The study is examining the effectiveness of 'Therabot', an AI chatbot designed to provide supportive behavioral interventions to individuals with mental health conditions such as anxiety, depression, or disordered eating.

What are the potential side effects?

Since this intervention involves a chatbot providing psychological support rather than medication or medical procedures, traditional physical side effects are not expected. However, users may experience emotional discomfort or distress during interactions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms.

This trial's timeline: 3 weeks for screening, Varies for treatment, and each participant in the depression cohort will fill out a questionnaire to establish baseline symptoms, and they will fill out this questionnaire again after 4 and 8 weeks of using the therapy chatbot to track changes in their symptoms. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Anxiety Symptoms

Depressive Symptoms

Eating Disorders Symptoms

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ExperimentalExperimental Treatment1 Intervention

This group will have access to the Therabot smartphone application. They will interact with the generative chatbot daily to discuss their mental health. Each participant in this group will have some benchmark symptoms of depression, anxiety, or eating disorders. They will fill out questionnaires every 4 weeks to describe changes in symptoms.

Group II: ControlActive Control1 Intervention

This group will not have access to the Therabot App. They will fill out questionnaires every 4 weeks to describe changes in symptoms. Each participant in this group will have some benchmark symptoms of depression, anxiety, or eating disorders.

Do I qualify?Apply below to find out